Retour sur lavenir.net
   SYENSQO 46.780 € (+3,06 %)     AB INBEV 59.060 € (+0,10 %)     ACKERMANS V.HAAREN 263.200 € (+0,84 %)     GBL 76.050 € (+0,33 %)     KBC 103.850 € (-0,48 %)     ARGENX SE 587.000 € (-0,20 %)     UCB 250.900 € (+0,93 %)     TUBIZE-FIN 212.000 € (+1,19 %)     NYXOAH 2.650 € (-2,21 %)     SOFINA 215.800 € (-0,28 %)     SOLVAY 25.320 € (+1,44 %)     BARCO 9.560 € (+0,26 %)     AZELIS GROUP 7.745 € (+3,96 %)     UMICORE 16.180 € (+2,80 %)     VGP 86.200 € (+0,70 %)     ONTEX GROUP 4.095 € (-1,09 %)     SHURGARD 25.300 € (+0,60 %)     AGEAS 59.700 € (+0,67 %)     QRF 11.050 € (+0,91 %)     AEDIFICA 70.150 € (+0,94 %)     WDP 22.600 € (+1,25 %)     COFINIMMO 82.200 € (+1,17 %)     ELIA GROUP 127.700 € (+0,79 %)     D'IETEREN GROUP 162.200 € (+0,43 %)     VASTNED 29.000 € (+0,35 %)     MELEXIS 50.550 € (-0,69 %)     ONWARD MEDICAL 3.520 € (0,00 %)     LOTUS BAKERIES 9 700.000 € (+0,73 %)     BEKAERT 39.850 € (+0,76 %)     PROXIMUS 7.045 € (+1,81 %)     MONTEA 65.600 € (+0,15 %)     KBC ANCORA 69.500 € (-0,29 %)     RECTICEL 9.100 € (-2,57 %)     ECONOCOM GROUP 1.430 € (-1,24 %)     ASCENCIO 49.750 € (+0,10 %)     TINC 11.160 € (+0,36 %)     TITAN S.A. 45.300 € (-0,11 %)     FLUXYS BELGIUM D 21.000 € (+2,94 %)     KINEPOLIS GROUP 25.150 € (+1,00 %)     BIOTALYS 1.685 € (+1,51 %)     CENERGY 18.380 € (+2,00 %)     EKOPAK 4.220 € (-3,21 %)     XIOR 26.850 € (+0,94 %)     CELYAD ONCOLOGY 0.330 € (+0,30 %)     DEME GROUP 183.200 € (-0,43 %)     OPTION 7.000 € (+1,45 %)     MOURY CONSTRUCT 710.000 € (+1,14 %)     NEXTENSA 43.600 € (+1,63 %)     CIE BOIS SAUVAGE 313.000 € (-1,57 %)     GIMV 44.100 € (+0,80 %)     WERELDHAVE BELGIUM 54.200 € (+0,74 %)     HOME INVEST BE. 18.440 € (0,00 %)     CMB.TECH 10.780 € (+1,13 %)     FAGRON 21.800 € (+1,16 %)     QUESTFOR GR-PRICAF 3.120 € (+1,94 %)     RETAIL ESTATES 65.600 € (+2,02 %)     EVS BROADC.EQUIPM. 32.750 € (0,00 %)     BPOST 1.810 € (-0,55 %)     CARE PROPERTY INV. 12.120 € (+0,83 %)     AGFA-GEVAERT 0.463 € (-0,54 %)  
   ACCOR 40.580 € (+0,77 %)     AIRBUS 163.740 € (-1,60 %)     Vusion 105.100 € (-0,10 %)     HERMES INTL 1 664.000 € (+0,88 %)     SAFRAN 283.300 € (-1,39 %)     SENSORION 0.391 € (-4,63 %)     POXEL 0.236 € (-2,07 %)     ATEME 9.000 € (+6,89 %)     CELLECTIS 2.965 € (-1,66 %)     SHELL PLC 39.225 € (+1,10 %)     TOTALENERGIES 76.000 € (0,00 %)     STMICROELECTRONICS 26.635 € (-1,35 %)     RENAULT 27.970 € (-0,32 %)     SAINT GOBAIN 70.400 € (-0,59 %)     BUREAU VERITAS 26.120 € (+0,46 %)     UMG 15.710 € (-0,16 %)     VALNEVA 2.914 € (+4,82 %)     IMCD 77.940 € (+5,32 %)     ING GROEP N.V. 21.985 € (-0,48 %)     DANONE 68.380 € (+0,15 %)     HEINEKEN 66.220 € (+0,73 %)     MAGNUM 12.602 € (-0,65 %)     CAPGEMINI 97.400 € (-0,86 %)     AEGON 6.024 € (+0,10 %)     TELEPERFORMANCE 48.960 € (-1,11 %)     ARCELORMITTAL SA 44.370 € (+0,36 %)     RANDSTAD NV 24.040 € (+0,71 %)     THALES 237.800 € (-0,54 %)     AVANTIUM 6.700 € (+1,16 %)     SOLUTIONS 30 SE 0.774 € (-2,95 %)     NEXITY 7.865 € (+0,13 %)     PHILIPS KON 23.240 € (+0,74 %)     DASSAULT SYSTEMES 16.895 € (-0,65 %)     MAUREL ET PROM 10.240 € (-0,87 %)     LVMH 467.100 € (+0,11 %)     JCDECAUX 19.360 € (-0,36 %)     ALSTOM 23.820 € (-0,58 %)     BNP PARIBAS ACT.A 83.260 € (-0,11 %)     SCHNEIDER ELECTRIC 239.250 € (-1,66 %)     KERING 251.100 € (+2,41 %)     L'OREAL 351.700 € (+1,97 %)     ARGAN 60.700 € (+1,17 %)     MICHELIN 28.880 € (+0,70 %)     BOUYGUES 49.280 € (-0,04 %)     CREDIT AGRICOLE 16.150 € (-0,19 %)     ORANGE 17.115 € (+0,91 %)     CLARIANE 3.548 € (-2,74 %)     BE SEMICONDUCTOR 182.200 € (-0,19 %)     DSM FIRMENICH AG 58.900 € (+1,34 %)     AALBERTS NV 30.420 € (-0,26 %)     ASM INTERNATIONAL 670.400 € (+0,51 %)     KENDRION 17.040 € (+2,04 %)     RELX 28.980 € (+1,83 %)     GETLINK SE 17.480 € (+0,81 %)     ASML HOLDING 1 177.400 € (+0,17 %)     ADYEN 888.800 € (+1,24 %)     WOLTERS KLUWER 64.520 € (+1,10 %)     FORVIA 9.476 € (-1,09 %)     PEUGEOT INVEST 61.400 € (+0,16 %)     SOITEC 48.630 € (-6,19 %)  
News Réglementées
11/03/2026 09:00

Original-Research: ATOSS Software SE (von NuWays AG): BUY

Original-Research: ATOSS Software SE - from NuWays AG

11.03.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to ATOSS Software SE

Company Name:ATOSS Software SE
ISIN:DE0005104400
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 148
Target price on sight of:12 months
Last rating change:
Analyst:Philipp Sennewald

Final FY25 reinforces quality compounder profile, Chg.

Yesterday’s publication of ATOSS’ FY25 annual report once again confirmed the exceptional quality of the business model and the structural strengths underpinning its long-term growth story. While the release contained no major surprises after the preliminary figures in January, it provides additional insight into the drivers behind ATOSS’ recurring revenue engine and its expanding AI-enabled platform.

FY25 marked another record year with group sales up 10.9% yoy to € 189m, while EBIT reached € 68.1m, corresponding to a 36% margin and thus exceeding the already lifted target of 34%. Recurring revenues (Cloud & Subscriptions + Maintenance) rose 18% yoy to € 132m and now account for 70% of total sales. At the same time, Cloud & Subscription revenues expanded by 28% yoy to € 92.7m and represent almost half of group revenues. These figures clearly highlight the continued success of ATOSS’ transition toward a highly scalable SaaS-based model.

Beyond the headline numbers, the report particularly underscores the strength of ATOSS’ recurring growth mechanics. Cloud ARR increased 28% yoy to € 101m, while the cloud order backlog rose 27% yoy to € 109m, providing a high level of revenue visibility entering FY26. Importantly, this growth is not only driven by new and migrated customer wins (60%) but also by consistent upselling within the installed base (40%), reflecting the company’s effective land-and-expand strategy and the mission-critical nature of its WFM solutions.

Another key takeaway is the increasing role of AI within the ATOSS platform. The company continues to integrate AI-driven functionality across forecasting, scheduling and workforce analytics processes, thereby further enhancing the value proposition of its software suite. In our view, this development strengthens ATOSS’ competitive positioning, as intelligent automation and predictive planning capabilities are becoming increasingly important differentiators in WFM solutions.

Despite ongoing investments into sales capacity, international expansion and AI development, ATOSS continues to deliver best-in-class profitability. The scalable SaaS model, combined with strong pricing power and disciplined cost management, enables EBIT margins comfortably in the mid-30% range (FY26e: 34.7%). At the same time, the company’s strong balance sheet remains a key strategic asset, with liquidity of more than € 120m providing ample flexibility for organic investments, dividends and potential bolt-on acquisitions.

Overall, the FY25 annual report once again reinforces our view that ATOSS represents a rare combination of structural growth, exceptional margins and high earnings visibility. With its expanding recurring revenue base, growing AI capabilities and strong balance sheet, the company remains one of the highest quality software compounders in the European market.

We therefore reiterate BUY with a new € 148 PT (old: € 152) based on DCF.
 

You can download the research here: atoss-software-se-2026-03-11-previewreview-en-f34a4
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2289274  11.03.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière